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Synaptic transmission relies on precisely regulated and exceedingly fast protein-protein
interactions that involve voltage-gated channels, the exocytosis/endocytosis machinery
as well as signaling pathways. Although we have gained an ever more detailed
picture of synaptic architecture much remains to be learned about how synapses are
maintained. Synaptic chaperones are “folding catalysts” that preserve proteostasis by
regulating protein conformation (and therefore protein function) and prevent unwanted
protein-protein interactions. Failure to maintain synapses is an early hallmark of several
degenerative diseases. Cysteine string protein (CSPα) is a presynaptic vesicle protein
and molecular chaperone that has a central role in preventing synaptic loss and
neurodegeneration. Over the past few years, a number of different “client proteins” have
been implicated as CSPα substrates including voltage-dependent ion channels, signaling
proteins and proteins critical to the synaptic vesicle cycle. Here we review the ion channels
and synaptic protein complexes under the influence of CSPα and discuss gaps in our
current knowledge.
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ONE J PROTEIN: THE TOTAL PROTECTION PLAN
Cysteine String Protein (CSPα) is a presynaptic vesicle pro-
tein with neuroprotective activity. In humans, mutations in the
DNAJC5 gene encoding CSPα that produce heterozygous CSPα
point mutations or point deletions cause autosomal-dominant,
adult onset neuronal ceroid lipofusinosis (ANCL), a neurode-
generative disorder characterized by accumulation of lysosomal
cellular debris (Benitez et al., 2011; Nosková et al., 2011; Velinov
et al., 2012). Disease onset is between 20–30 years of age and
the course and outcome of ANCL involves, increased anxiety,
speech difficulties, ataxia, involuntary movements, seizures, cog-
nitive deterioration, dementia with a shortened life expectancy. In
mice, CSPα KO causes activity-dependent synapse loss, progres-
sive defects in neurotransmission and neurodegeneration verify-
ing CSPα’s anti-neurodegenerative function (Fernández-Chacón
et al., 2004; García-Junco-Clemente et al., 2010). CSPα heterozy-
gote mice, which have reduced levels of CSPα, are phenotypically
normal suggesting that wild type mice normally have “extra”
CSPα protection (Fernández-Chacón et al., 2004). In Drosophila
melanogaster, CSPα KOs that survive to adulthood demonstrate
temperature-sensitive paralysis, uncoordinated movement, shak-
ing and early death (Zinsmaier et al., 1994). It is clear that the
function of CSPα is to protect the synapse, what is not known is
the mechanism(s) underlying the prevention of synapse loss by
CSPα. Understandably, much effort has focused on delineating
the cellular pathway of CSPα-mediated protection.
THE CSPα TRIMERIC COMPLEX
CSPα contains a “J-domain” which is a ∼70-amino acid region
of homology shared by bacterial DnaJ and all other J proteins
as well as a palmitoylated cysteine-rich “string” region used for
membrane attachment to the outer leaflet of synaptic vesicles
(Braun and Scheller, 1995). Rather than being “constitutively
active” CSPα becomes active upon assembly with SGT (small
glutamine-rich tetratricopeptide repeat-containing protein) and
Hsc70 (70-kDa heat-shock cognate protein) (Braun et al., 1996;
Tobaben et al., 2001). Hsc70 is a central hub of the cellular
chaperone network (Craig et al., 2006; Kakkar et al., 2012),
and it follows that collapse of Hsc70 would be expected to
cause collapse of the J protein network. Each member of the
J protein family—there are 49 J proteins in Homo sapiens—
has a J domain that activates Hsc70’s ATPase activity for con-
formational work on diverse “client proteins” (Kakkar et al.,
2012). Outside of the J domain, J proteins have little, if any,
structural similarity. These non-homologous regions are, almost
certainly, determinants of J protein specificity but do not provide
much clarity into the functionality of specific J proteins. Since
other J proteins do not compensate, CSPα is generally viewed
as facilitating highly specific folding events. In vitro, mutation
of the invariant tripeptide of histidine, proline and aspartic acid
(HPD motif) located between helices II and III of CSPα’s four
α helical J domain creates a loss-of-function mutant that does
not activate Hsc70 (Chamberlain and Burgoyne, 1997). CSPα
is also found in non-neuronal secretory cells including exocrine
(Braun and Scheller, 1995; Zhao et al., 1997; Weng et al., 2009),
endocrine (Brown et al., 1998; Zhang et al., 2002) and neuroen-
docrine (Kohan et al., 1995; Chamberlain et al., 1996) secretory
granules and mammary cell small vesicles (Gleave et al., 2001).
That said, the reduced life-span in CSPα KO mice is due to
neurodegeneration.
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THE INTERVAL PRECEDING FULMINANT
NEURODEGENERATION
CSPα KO mice appear normal at birth, but around postnatal day
20, they develop progressive motor deficits and CNS degenera-
tion, followed by early lethality between days 40–80 (Fernández-
Chacón et al., 2004). In this context it is noteworthy that CSPα
is not required for neurotransmitter release but only necessary to
maintain synaptic function and architecture. Which client proteins
are critical for triggering the cascade of events leading to degenera-
tion? The field is now turning to better appreciate the age interval
of CSPαKO mice when the demise of the synapse is likely to begin.
While this early window remains to be fully dissected, we know
that around 20 proteins have altered expression patterns by P28
and that these proteins represent potential primary “misfolding
events” (Zhang et al., 2012). Activity-dependent degeneration
in mice and temperature-sensitive paralysis in Drosophila are
distinguishing features of CSPα null models. In mice, synapses
that fire frequently, such as those associated with photorecep-
tors and GABAergic neurons, are lost first (Schmitz et al.,
2006; García-Junco-Clemente et al., 2010). Early impairments
in motor terminals are characterized by a failure to sustain
prolonged release and impaired synaptic vesicle recycling (Rozas
et al., 2012). In Drosophila, the ∼50% reduction of nerve-evoked
neurotransmitter release at 18–22◦C and a drastic temperature-
sensitive reduction in evoked release above 29◦C is well estab-
lished (Umbach et al., 1994; Zinsmaier et al., 1994; Nie et al.,
1999; Dawson-Scully et al., 2000, 2007; Arnold et al., 2004; Bronk
et al., 2005). Activity-and temperature-dependent degeneration
in CSPα KO reflect the idea that nerve terminals are particu-
larly vulnerable to misfolding and that CSPα is indispensable
to refolding and repair. It is likely that CSPα is designed to
facilitate folding of multiple “client proteins” whose unfolding
leads to a second set of separate downstream degenerative events.
However, many questions remain regarding CSPα’s “protein client
lineup”.
“RESCUE” OF CSPα KO MICE
Endogenous J proteins do not serve as “back ups” for the dele-
tion of CSPα, however, overexpression of α-synuclein abrogates
motor impairments and lethality in CSPα KO mice while KO of
endogenous α-synuclein speeds up neurodegeneration (Chandra
et al., 2005). Of note, mice deficient in α-synuclein do not have
an obvious phenotype (Chandra et al., 2005). α-synuclein is a
soluble presynaptic protein of unknown function that associates
with synaptic vesicles and is the major component of Lewy bodies,
a landmark of Parkinson’s disease and other neurodegenerative
disorders (Maroteaux et al., 1988; Burré et al., 2010). CSPα/α-
synuclein do not interact and Hsc70 ATPase is not activated
by α-synuclein, hence, while CSPα and α-synuclein may target
common “client proteins” they are nonetheless mechanistically
distinct (Chandra et al., 2005). Somewhat paradoxically, treat-
ment of CSPα KO mice with proteasome inhibitors ameliorates
neurodegeneration and extends the life-span of CSPα KO mice
(Sharma et al., 2012b). Thus, the neurodegeneration observed
in CSPα KO mice is not due to a reduction in the protea-
some capacity and the consequential elevation of ubiquintinated
synaptic proteins. While the physiological implications of these
findings have not yet been elucidated, rescue of degeneration
in CSPα KO mice serves as proof-of-principle for interven-
tion in nerve terminal failure and synapse loss and may pave
the way for development of therapeutic agents that prevent
neurodegeneration.
EXOCYTOSIS AND ENDOCYTOSIS MACHINERY
SNARE (soluble N-ethylmalemide-sensitive factor attachment
receptors) proteins are fundamental to presynaptic vesicle-release
events and for that reason have been closely scrutinized as
possible CSPα “clients”. The t-SNARE, SNAP25 (synaptoso-
mal associated protein of 25 kDa) expression is decreased in
CSPα KO mice (Chandra et al., 2005; Zhang et al., 2012).
However, it is the effective assembly/disassembly of SNAP25
into the SNARE complex during repeated rounds of exocyto-
sis/endocytosis that correlates with the maintenance of synaptic
function rather than cellular levels of SNAP25 (Sharma et al.,
2011b, 2012a). While neurodegeneration is rescued by over-
expression of wild-type, but not inactive mutants of SNAP-25,
the decline in SNAP25 expression per se is unlikely to be a
primary cause of neurodegeneration, as SNAP25 heterozygous
mice with ∼50% reduction in SNAP25 levels are phenotypically
normal (Washbourne et al., 2002; Sharma et al., 2011b). Fur-
thermore, the dramatic rescue of neurodegeneration in CSPα
KO mice by α-synuclein, rescues the association of SNAP25 with
other SNAREs but does not ameliorate the decrease in SNAP-
25 expression (Sharma et al., 2011b, 2012a). More recently, it
was shown that treatment of CSPα KO mice with proteasome
inhibitors reverses impairment of SNARE-complex assembly and
alleviates neurodegeneration (Sharma et al., 2012b). CSPα has
also been shown to interact with the t-SNARE, syntaxin (Nie
et al., 1999; Evans et al., 2001) and the Ca2+ binding pro-
tein, synaptotagmin (Evans and Morgan, 2002), emphasizing its
role in chaperoning the exocytosis machinery. Taken together,
degeneration in CSPα KO mice is halted by interventions that
correct SNARE complex function including interventions that
influence SNARE complex assembly without elevating SNAP25
levels. A separate line of investigation has revealed that CSPα
KO mice also have an endocytosis defect resulting in the failure
to recycle and maintain the size of the synaptic vesicle pool
during prolonged stimulation (Rozas et al., 2012). In fact, early
on (P28) in the course of degeneration the GTPase, dynamin
1, which is essential for endocytosis, is reduced by ∼40% in
CSPα KO mice (Zhang et al., 2012). CSPα directly interacts
with dynamin 1 to promote polymerization, a process required
in membrane fission (Zhang et al., 2012), however the mecha-
nistic details linking endocytosis and CSPα dysfunction remain
to be established. Insights into exocytosis/endocytosis defects
will undoubtedly prove to be important in understanding the
pathological uncoupling between presynaptic exocytosis and
endocytosis.
PRESYNAPTIC ION CHANNELS: CHANNEL PROTEOSTASIS
AND MULTI-PROTEIN COMPLEXES
Do changes in presynaptic ion channels or ion channel com-
plexes trigger the activity-dependent and temperature-dependent
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neurodegeneration in CSPα-KO mice? We have shown that large
conductance Ca2+-and voltage-activated K+ (BK) channels are
∼2.5 fold higher in the brain of CSPα null mice compared
with age-matched wild types (Kyle et al., 2013). This increase
in expression is observed at an early age (i.e., P23-P27), when
levels of neuronal Kv1.1, Kv1.2 and Cav2.2 do not change.
Physiologically, BK channels are activated by membrane depo-
larization and/or elevations in intracellular Ca2+ and drive the
membrane potential towards the K+ equilibrium potential. Under
normal conditions, BK channels regulate repolarization of the
action potential, thereby regulating excitability of neurons, as
well as presynaptic neurotransmitter release. Further, ectopic
expression of dysfunctional CSPα mutants (i.e., CSPαHPD-AAA,
CSPαL116∆, CSPαL115R) also elicits elevation of BK channel
expression and macroscopic current density (Kyle et al., 2013;
Ahrendt et al., 2014) suggesting that the observed increase, at
least initially, reflects an elevation of functional, rather than mis-
folded or aggregated BK channel protein. CSPαHPD-AAA is a loss-
of-function mutant in which the essential J domain required for
activation of Hsc70ATPase is disrupted but the cysteine string
anchor is functional. The increase found in the presence of
this loss-of-function mutant is consistent with the increase in
BK channel expression observed in CSPα null mice. On the
other hand, while CSPαL116∆ and CSPαL115R increase BK channel
density at the membrane, the increase is not as large as that
observed with CSPαHPD-AAA (Kyle et al., 2013), suggesting that
CSPαL116∆ and CSPαLL115R are partial loss-of-function mutants.
In humans, deletion of residue 116 or replacement of Lys115
by Arg in the cysteine string region results in ANCL (Benitez
et al., 2011; Nosková et al., 2011; Velinov et al., 2012), however
the mechanism(s) underlying disease pathology is not known.
It is becoming increasingly clear that changes in the cysteine
string region can promote oligomerization. Wild type CSPα self-
associates (Braun and Scheller, 1995) and this dimerization is
eliminated in the absence of the cysteine string region (Xu et al.,
2010). When expressed in bacteria, which lack eukaryotic palim-
itoyltransferase enzymes, CSPα forms oligomers and the cysteine
string region is important for the self-association (Swayne et al.,
2003). Two mutations in the cysteine string region of CSPα,
L116∆ and L115R, do not effectively anchor to synaptic vesicles
and form oligomers indicating the cysteine string region is closely
tied to oligomerization properities (Greaves et al., 2012). Clearly,
identification of the neuronal location of CSPαL116∆/CSPαL115R
oligomers is central to understanding ANCL disease progression.
Thus, disruption of the anchor to the synaptic vesicle while
maintaining the functional J domain in the CSPαL116∆ and
CSPαL115R mutants and subsequent CSPα oligomerization and
cellular mislocalization likely leads to indiscriminate chaperone
activity. We speculate that CSPαL116∆ and CSPαL115R cause both
a partial loss-of-function (i.e., reduced chaperone activity at the
synaptic vesicle) as well as gain-of-function (i.e., increased chap-
erone activity at a different cellular location). Consistent with this
notion, CSPα heterozygote mice do not show neurodegeneration
while ANCL patients show adult-onset neurodegeneration most
likely due to mislocalized/oligomerized mutant CSPα chaperone
activity outside the presynapse. Do changes in BK channel activity
link to neurological disorders or neurodegeneration? Several studies
have reported that alterations in the expression and function
of BK channels give rise to neural dysfunction. For example,
genetic deletion of BK channel subunits in mice (Sausbier et al.,
2004; Brenner et al., 2005) and a gain-of-function channel muta-
tion in humans (Du et al., 2005; Díez-Sampedro et al., 2006)
are associated with ataxia and epilepsy, while functional alter-
ations are associated with retardation, schizophrenia and autism
(Laumonnier et al., 2006; Zhang et al., 2006; Higgins et al.,
2008; Deng et al., 2013). Clearly, when BK channel activity is
disrupted, neural excitability and neurotransmitter release are
disrupted, but neurodegeneration per se does not typically ensue
raising a number of interesting questions. Does the fulminant,
activity-dependent neurodegeneration seen in CSPα KO mice result
from a coupling of aberrant BK channel expression with synaptic
vesicle release/recycling defects? What underlies the rapid rate of
degeneration in CSPα KO mice. Further, are complexes of BK
channels with other synaptic proteins regulated by CSPα? BK
channels are subject to a wide array of regulatory processes,
including interactions with SNARE proteins (Ling et al., 2003);
however the precise details of these channel complexes in CSPα
KO mice remain to be investigated. We speculate that CSPα
directly modulates BK channel density, nonetheless this is not
a foregone conclusion. Future experiments will undoubtedly
establish whether CSPα acts indirectly via one of the known
regulators of BK channel activity or by directly targeting the
channels.
Do functional and/or structural changes in voltage-dependent
Ca2+channels occur early in the pathological sequence of events
underlying neurodegeneration in CSPα KO mice? Whether CSPα
directly regulates Ca2+currents remains contentious. Ca2+ entry
into presynaptic nerve terminals is fundamental to neurotrans-
mission and consequently subject to multiple levels of control. A
large body of work has clarified that neurotransmission defects
at the neuromuscular junction involve a decrease in quantal con-
tent, a reduction in the calcium sensitivity of evoked exocytosis
and anomalous bursts of spontaneous neurotransmitter release
(Umbach et al., 1994; Zinsmaier et al., 1994; Dawson-Scully et al.,
2000, 2007; Ruiz et al., 2008). Further, recruitment of Ca2+ chan-
nels (Chen et al., 2002) as well as physical interactions of CSPα
with N-type and P/Q type voltage-dependent Ca2+ channels have
been demonstrated (Leveque et al., 1998; Miller et al., 2003a,b;
Swayne et al., 2005, 2006). Whether it is the synaptic vesicle-
anchored monomeric CSPα or the mislocalized CSPα oligomers
that regulate Ca2+currents requires further investigation. We
have found that CSPα influences the regulation of N-type Ca2+
channels by heterotrimeric GTP binding proteins (Magga et al.,
2000; Miller et al., 2003b; Natochin et al., 2005). There are
still many unanswered questions regarding the role of CSPα in
regulating synaptic channels and synaptic channel complexes. The
CSPα KO mouse model offers an excellent opportunity to study
channel proteostasis and channel complexes that may contribute
to activity-dependent neurodegeneration. How CSPαmight func-
tion in different secretory cells (e.g., pancreatic exocrine and
endocrine cells), given the differences in their complement of
ion channels, also remains to be determined. Further efforts will
be needed to untangle the neuroprotective pathway(s) involving
CSPα at the synapse and to establish precisely the complement
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of synaptic channels involved in the cascade of neurodegenerative
events triggered by the absence of CSPα.
In summary, ion channels are physiologically regulated within
tight limits and present evidence implicates the presynaptic
molecular chaperone CSPα in the fine-tuning of functional chan-
nel levels and regulation of synaptic channel complexes. In the
future, it will be interesting to determine whether CSPα is also
important for the quality control of mis-folded/aberrant chan-
nels. The time course of the expression changes in SNAP25,
dynamin 1 and synaptic channels in CSPα KO mice remains a key
question.
JEOPARDIZING THE SYNAPSE: LINKS TO ALZHEIMER’S AND
PARKINSON’S DISEASE
Clearly, the dysfunction of CSPα is linked to undesired conse-
quences. Neurodegenerative diseases such as Alzheimer’s disease
and Parkinson’s disease show a characteristic loss of neurons
and synapses (Muchowski and Wacker, 2005). The identifica-
tion of CSPα as a central chaperone for the maintenance of
synapses raises the questions: are cellular CSPα-neuroprotective
pathways compromised in neurodegenerative disorders other than
ANCL? Do functionally impaired proteins that build up in neu-
rodegenerative disorders interfere with CSPα chaperone activity?
It is noteworthy that lysosomal lipofuscin inclusions, like those
seen in ANCL, are present in very early onset (age 30) and
rapidly progressing Alzheimer’s disease caused by presenilin 1
mutations (Dolzhanskaya et al., 2014). Moreover, CSPα is reduced
in the frontal cortex of humans with Alzheimer’s disease (Zhang
et al., 2012) and SNARE complex assembly is impaired in human
brain tissue from patients with Alzheimer’s Disease and Parkin-
son’s Disease (Sharma et al., 2012b). Interference with CSPα,
SNARE complex assembly, dynamin 1 assembly and ion channel
complexes by impaired/toxic proteins typically found in neurode-
generative disorders may, at least in part, contribute to neurode-
generation and these possibilities will undoubtedly be the focus of
future investigations.
FUTURE PERSPECTIVES
When CSPα is compromised, protein surveillance and proteosta-
sis mechanisms in the neuron fail and the integrity of pre-synaptic
terminals is compromised. The field is now poised to tackle in
detail the pathogenic sequence of events responsible for activity-
dependent neurodegeneration in the absence of CSPα chaperone
activity. The emerging detailed molecular blueprint will undoubt-
edly serve investigators well in the development of therapeutics
that protect against synaptic loss in neurodegenerative disorders.
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